U.S., Aug. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07776028) titled 'Efficacy and Safety of Dallixa(R) Eyelash Serum in Idiopathic Eyelash Hypotrichosis' on Aug. 17.
Brief Summary: Efficacy and Safety of Dallixa(R) Eyelash Serum in Idiopathic Eyelash Hypotrichosis
Study Start Date: Aug. 28, 2025
Study Type: INTERVENTIONAL
Condition:
Hypotrichosis
Intervention:
DRUG: dermo cosmetic product
dermo cosmetic products like herbal or vitamin ingredients
Recruitment Status: COMPLETED
Sponsor: Quantum Aesthetics Cosmetics
Disclaimer: Curated by HT Syndication....